Many tools for breast cancer screening and early detection are under study.
Some tools are already used in breast cancer diagnosis and staging and are widely available. These tools have been studied for use in screening more than others and include:
Other tools under study for use in breast cancer screening include:
These and other topics are discussed below.
More research is needed on these tools to know whether they may play a role in breast cancer screening for all women or certain groups of women at higher risk.
Special imaging machines can take multiple, standard two-dimensional (2D) digital mammograms. Computer software combines the 2D X-ray images into a three-dimensional (3D) image (called breast tomosynthesis).
Radiologists must have special training to read these 3D images.
Breast tomosynthesis is not a substitute for 2D mammography. It is done in combination with 2D mammography.
A breast tomosynthesis machine provides both a standard 2D digital mammogram and an enhanced 3D image based on the 2D images.
All of the X-rays are taken on the same machine, so a woman getting breast tomosynthesis in combination with a standard mammogram stays in one place while all of the images are taken.
Because more X-rays are taken, breast tomosynthesis gives a higher radiation dose as mammography (this higher dose is still within FDA guidelines) [15,62,67].
Some studies have suggested 2D mammography plus breast tomosynthesis may find a few more breast cancers than 2D mammography alone [62,68-70]. The exact benefit is still under study [62,68-70].
However, 2D mammography plus breast tomosynthesis is available at some centers and may be considered for breast cancer screening.
Nuclear medicine breast imaging (also called molecular breast imaging) uses short-term radioactive agents that are given through an IV. These agents are absorbed into tissues, including the breast.
Breast cancer cells appear to absorb more of the agents than healthy cells. The cancer cells can then be imaged with a special camera.
Nuclear medicine breast imaging is under study for use in breast cancer screening, diagnosis and staging. Some studies are looking at the combination of nuclear medicine breast imaging and mammography for screening women with dense breasts .
A woman getting nuclear medicine breast imaging is positioned in a similar way as with mammography. Each breast is pressed between two plates and the machine takes images.
Two types of nuclear medicine imaging techniques are:
A main concern about the use of BSGI and PEM for screening is that they give a dose of radiation 15-20 times higher than the dose from a mammogram . Ways to lower the amount of radiation exposure are under study .
Although still under study, BSGI and PEM are used in clinical practice, but are not widely available.
Thermography uses infrared light to measure temperature differences on the surface of the breast.
Breast cancer may cause abnormal heat patterns. However, there is no solid scientific evidence that thermography measures of heat can help find breast cancers .
Neither the U.S. Food and Drug Administration (FDA) nor the American College of Radiology views thermography as a useful breast screening or imaging tool [72,75].
In 2011, the FDA issued an alert warning the public about misleading claims by thermography practitioners and manufacturers on the screening benefits of the tool . To read the full alert, visit the FDA website.
If you are interested in joining a clinical trial studying new screening methods, talk with your health care provider.
BreastCancerTrials.org in collaboration with Susan G. Komen offers a custom matching service to help you find a clinical trial on breast cancer screening.
Learn more about clinical trials.
Our commitment to research
At Susan G. Komen©, we are committed to saving lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer. Our Research Program is an essential driving force for achieving this mission. Since our inception in 1982, Komen has provided funding to support research grants that have greatly expanded our knowledge of breast cancer and helped us understand that breast cancer is not just a single disease but many diseases, unique to each individual. Going forward, our commitment to research will contribute significantly to our ability to achieve our bold goal of reducing the current number of breast cancer deaths in the U.S. by 50 percent by 2026.
To date, Komen has provided more than $920M to researchers in 48 states and 21 countries to support research that has resulted in a better understanding of breast cancer; earlier detection; personalized, less invasive treatments for what was once a “one-treatment-fits-all” disease; and improvements in both quality of life and survival rates.
Learn more about our continuing investment in research and the exciting research that we are funding, because nothing would make us happier than ending breast cancer forever.
Komen funds research looking at new methods of early detection.
One new method is breast ultrasound tomography, a tool that uses ultrasound technology. Breast ultrasound tomography may give information on breast density by measuring the speed that sound waves travel through the breast .
Komen is also funding research on the use of molecular breast imaging for screening women with dense breasts.
Learn about the latest research on breast ultrasound tomography, molecular breast imaging and other topics that Komen is funding in our Stories of Discovery.
Facts for Life: Breast Imaging Methods
Research Fast Facts: Early Detection
1-877 GO KOMEN(1-877-465-6636)